GRANDVIEW MEDICAL CENTER — History
CCN 010104 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$615M
Latest Revenue (FY2022)
+7.5%
Revenue CAGR (3yr)
14.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $533M | $563M | $615M | +9.3% | +7.5% |
| Operating Expenses | $446M | $466M | $528M | +13.3% | +8.8% |
| Operating Margin | 16.2% | 17.2% | 14.2% | -17.6% | -6.5% |
| Net Income | $86M | $97M | $87M | -9.9% | +0.5% |
| Licensed Beds | 405 | 405 | 404 | -0.2% | -0.1% |
| Total Patient Days | 115,638 | 118,144 | 124,020 | +5.0% | +3.6% |
| Medicare Day % | 23% | 20% | 21% | +2.8% | -5.3% |
| Medicaid Day % | 12% | 13% | 14% | +1.2% | +4.5% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.5% ($533M → $615M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.5%
This Hospital
+7.6%
State Avg
Latest Margin
14.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $657M | 13.1% |
| FY2024 (proj) | $698M | 12.1% |
| FY2025 (proj) | $739M | 11.1% |